Spots Global Cancer Trial Database for Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Postmarketing Prospective Study of Melanoma Patients Treated With IMLYGIC® to Characterize Risk of Herpetic Infection
Official Title: A Postmarketing Prospective Cohort Study of Melanoma Patients Treated With IMLYGIC® in Clinical Practice to Characterize Risk of Herpetic Infection Among Patients, Close Contacts, Health Care Providers & Long-term Safety in Treated Patients
Study ID: NCT02910557
Interventions
Study Description
Brief Summary: A postmarketing Cohort study of Melanoma patients treated with IMLYGIC (Talimogene Laherparepvec) in clinical Practice to Characterize the risk of herpetic infection with detection of Talimogene Laherparepvec DNA among patients, close contacts, and health care providers; and long term safety in treated patients for up to 5 years after the first IMLYGIC dose.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mercy Medical Center, Baltimore, Maryland, United States
Jefferson City Medical Group PC, Jefferson City, Missouri, United States
TriHealth Cancer Institute - Kenwood, Cincinnati, Ohio, United States
University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
University of Tennessee Medical Center, Knoxville, Tennessee, United States
Intermountain Medical Center, Murray, Utah, United States
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Medizinische Universitaet Graz, Graz, , Austria
Ordensklinikum Linz Elisabethinen, Linz, , Austria
Landeskrankenhaus Salzburg, Salzburg, , Austria
Universitaetsklinikum Sankt Poelten, Sankt Poelten, , Austria
Rambam Medical Center, Haifa, , Israel
Sheba Medical Center, Ramat Gan, , Israel
Universitaetsspital Basel, Basel, , Switzerland
Kantonsspital Graubuenden, Chur, , Switzerland
Universitaetsspital Zuerich, Zuerich Flughafen, , Switzerland
Cheltenham General Hospital, Cheltenham, , United Kingdom
Guys Hospital, London, , United Kingdom
Royal Marsden Hospital, London, , United Kingdom
Churchill Hospital, Oxford, , United Kingdom
Musgrove Park Hospital, Taunton, , United Kingdom
Contact Details
Name: MD
Affiliation: Amgen
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
